Your browser doesn't support javascript.
loading
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.
Tan, Kien Thiam; Yeh, Chun-Nan; Chang, Yu-Chan; Cheng, Jen-Hao; Fang, Wen-Liang; Yeh, Yi-Chen; Wang, Yu-Chao; Hsu, Dennis Shin-Shian; Wu, Chiao-En; Lai, Jiun-I; Chang, Peter Mu-Hsin; Chen, Ming-Han; Lu, Meng-Lun; Chen, Shu-Jen; Chao, Yee; Hsiao, Michael; Chen, Ming-Huang.
Afiliação
  • Tan KT; ACT Genomics Co., Ltd, Taipei, Taiwan.
  • Yeh CN; Department of Surgery, Liver Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
  • Chang YC; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Cheng JH; ACT Genomics Co., Ltd, Taipei, Taiwan.
  • Fang WL; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Yeh YC; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Wang YC; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Hsu DS; Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Wu CE; Institute of Biomedical Informatics, National Yang-Ming University, Taipei, Taiwan.
  • Lai JI; Preventive Medicine Research Center, National Yang-Ming University, Taipei, Taiwan.
  • Chang PM; Asclepiumm Taiwan Co., Ltd, New Taipei, Taiwan.
  • Chen MH; Department of Surgery, Liver Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
  • Lu ML; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Chen SJ; Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chao Y; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Hsiao M; Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chen MH; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
J Immunother Cancer ; 8(1)2020 03.
Article em En | MEDLINE | ID: mdl-32238472

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan